News | Artificial Intelligence | October 24, 2019

Medical AI software company and U.S. cancer center operator partner to further advance early detection and characterization of various cancers with artificial intelligence

Enlitic Announces Strategic Partnership With Select Healthcare Solutions

October 24, 2019 — Artificial intelligence (AI) software developer Enlitic Inc. announced it has signed a strategic partnership with Select HealthCare Solutions, a developer, owner and operator of cancer centers across the U.S. As part of the agreement, Enlitic will receive access to Select Healthcare’s high-quality, anonymized patient data –– data that will further tune Enlitic’s predictive models for early cancer detection. In turn, Select HealthCare will receive access to Enlitic’s AI software technology and will directly contribute to the development of future Enlitic products in radiology, oncology and pathology.

Enlitic’s deep learning models have demonstrated potential for the early detection of malignancies. In an independent validation study from 2017, Enlitic's algorithm was found to detect lung nodules with 91.1 percent sensitivity at time of biopsy, operating on par with state-of-the-art computer-aided detection (CAD), but with much higher specificity. Furthermore, the algorithm was shown to detect malignancies 6 and 12 months before biopsy, and reliably caught cancerous nodules 17.5 months earlier than when a biopsy was ordered.

Enlitic’s partnership with Select HealthCare adds to Enlitic’s global partnership roster of healthcare and technology companies, including Capitol Health, a leading Australian healthcare provider; Marubeni Corp., a Japan-based global conglomerate; and Konica Minolta, a multinational technology company also based in Japan.

“Enlitic’s diagnostic AI software is crucial to improving patient care in the future and we are excited to join the company’s list of world-class partners by providing comprehensive multimodal data that will help revolutionize how cancer is detected and treated,” said Matthew Cutler, president and CEO of Select HealthCare Solutions. “We believe that our clinical experience in treating complex cancers, combined with Enlitic’s best-in-class technologies and experience in early disease detection, will ultimately help save millions of lives.”

For more information: www.enlitic.com


Related Content

News | Breast Imaging

Aug. 28, 2024 — Rezolut, LLC recently debuted its latest offering for patients during their annual mammogram ...

Time August 29, 2024
arrow
News | Digital Pathology

Paige has launched OmniScreen, an AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 ...

Time August 27, 2024
arrow
News | RSNA

July 31, 2024 — The National Imaging Informatics Course (NIIC), a pioneering program in the radiology field, will return ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Artificial Intelligence

July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced a strategic ...

Time July 26, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Subscribe Now